Webinars
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...
View Now
Webinars
Exploring New and Improved Analytical Methods for Traditional and Unique Modalities
Summary: During this presentation, experts will discuss the latest challenges in biophysical characterization and will present solutions to overcome these challenges.
View Now
Webinars
Endpoints 11 – BioPharma’s Most Promising Startups in 2021
Summary: This will be Endpoints’ 2021 look at 11 of the most important up-and-coming private biotechs in the business, independently selected by company founder and editor John Carroll.
View Now
Webinars
Biologics Analytical Methods: Trends and Strategies to Accelerate Biologics Development
Summary: This webinar summarizes the current bioanalytical landscape and its challenges, and discusses strategies to overcome them.
View Now
Webinars
The Post-COVID Pipeline Takes Shape: New Vaccines and Drugs During the mRNA Revolution
Summary: In this webinar, leaders in the field discuss new vaccines and drugs that have resulted from COVID and key learnings to prepare for the next pandemic.
View Now
Webinars
ASCO Explained: Expert Predictions for the World’s Biggest Cancer Meeting
Summary: This roundtable discussion offers a closer look at oncology's hottest fields, including CAR-T and precision medicine, 2021's biggest research trends and the data they're most looking forward to seeing.
View Now
Webinars
Harnessing mRNA as a Readout to Develop Robust BioPotency Assays
Summary: Catalent has developed a relative potency bioassay using real-time quantitative reverse transcription (RT-qPCR) in a duplex format to assess relative transcription activity in cells treated with ligands or transgenic vectors.
View Now
Webinars
Pharma Predictions for 2021
Summary: Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.
View Now
Webinars
Women in Biopharma Awards 2020
Summary: Gwen Green, VP of Commercial Excellence at Catalent, and Endpoints News editors highlight the top 20 women in biopharma who have made it to the upper echelons of the drug development business in this on-demand webinar.
View Now
Webinars
Supply Chain Contingencies to Avoid Upheaval
Summary: Karen Flynn, President of Biologics and Chief Commercial Officer, explains the challenges and opportunities changing how biomedical supply chains must plan and innovate to continue to serve patients and build resilient future options.
View Now